Nature Medicine, Published online: 12 February 2026; doi:10.1038/s41591-025-04139-y A follow-up analysis of a clinical trial that evaluated anti-PD-1 therapy in patients with cancer who are living with HIV provides mechanistic insights into transcriptomic, cellular and cytokine changes related to immune checkpoint inhibitor treatment and identifies a signature associated with clinical response.
Nature Medicine, Published online: 12 February 2026;
doi:10.1038/s41591-025-04139-y
A follow-up analysis of a clinical trial that evaluated anti-PD-1 therapy in patients with cancer who are living with HIV provides mechanistic insights into transcriptomic, cellular and cytokine changes related to immune checkpoint inhibitor treatment and identifies a signature associated with clinical response.
β Source: Nature Medicine (https://www.nature.com/articles/s41591-025-04139-y)